| 1.68 0.2 (13.51%) | 12-01 15:59 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.05  |
1-year : | 2.33 |
| Resists | First : | 1.76 |
Second : | 2 |
| Pivot price | 1.47 |
|||
| Supports | First : | 1.37 | Second : | 1.14 |
| MAs | MA(5) : | 1.5 |
MA(20) : | 1.56 |
| MA(100) : | 2.16 |
MA(250) : | 2.37 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 37 |
D(3) : | 26.7 |
| RSI | RSI(14): 47.7 |
|||
| 52-week | High : | 6.98 | Low : | 1.29 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ENVB ] has closed below upper band by 0.2%. Bollinger Bands are 59.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.59 - 1.6 | 1.6 - 1.6 |
| Low: | 1.46 - 1.47 | 1.47 - 1.48 |
| Close: | 1.47 - 1.48 | 1.48 - 1.49 |
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Wed, 29 Nov 2023
Enveric Biosciences Inc (ENVB) Stock Is Down 0.00% This Week: Buy, Hold, or Sell? - InvestorsObserver
Wed, 29 Nov 2023
Enveric Biosciences Receives Notice of Allowance from USPTO for ... - Manchestertimes
Mon, 27 Nov 2023
Enveric Biosciences Announces Manuscript Describing the ... - StreetInsider.com
Fri, 24 Nov 2023
Enveric Biosciences Announces Presentation of Two Posters at ... - Yahoo Finance
Mon, 13 Nov 2023
Enveric Biosciences Reports Third Quarter 2023 Corporate and ... - Yahoo Finance
Fri, 20 Oct 2023
Enveric Biosciences to Present at the Centurion One 5th Global ... - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 2 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 12.5 (%) |
| Held by Institutions | 10.9 (%) |
| Shares Short | 19 (K) |
| Shares Short P.Month | 11 (K) |
| EPS | -11.52 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.12 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -61.5 % |
| Return on Equity (ttm) | -173.1 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -7.79 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -16 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.14 |
| PEG Ratio | 0 |
| Price to Book value | 1.42 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.24 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|